Have your own idea? Try our Stock Screener
Italian (Borsa Italiana) Healthcare Sector Analysis
UpdatedDec 07, 2025
DataAggregated Company Financials
Companies18
- 7D-1.4%
- 3M-10.9%
- 1Y-19.5%
- YTD-18.7%
Over the last 7 days, the Healthcare industry has dropped 1.4%, driven by a pullback from Recordati Industria Chimica e Farmaceutica of 4.2%. However, the industry is down 20% over the past year. As for the next few years, earnings are expected to grow by 12% per annum.
Sector Valuation and Performance
Has the Italian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 07 Dec 2025 | €20.5b | €8.8b | €886.9m | 19.7x | 23.2x | 2.3x |
| Tue, 04 Nov 2025 | €22.0b | €8.8b | €886.0m | 21.5x | 24.9x | 2.5x |
| Thu, 02 Oct 2025 | €22.5b | €8.8b | €895.5m | 20.7x | 25.1x | 2.6x |
| Sat, 30 Aug 2025 | €23.1b | €8.7b | €902.9m | 20x | 25.6x | 2.7x |
| Mon, 28 Jul 2025 | €24.6b | €8.6b | €941.3m | 20.8x | 26.2x | 2.9x |
| Wed, 25 Jun 2025 | €24.1b | €25.2b | €985.5m | 20.2x | 24.5x | 1x |
| Fri, 23 May 2025 | €22.8b | €25.2b | €985.5m | 19.3x | 23.2x | 0.9x |
| Sun, 20 Apr 2025 | €21.4b | €20.1b | €908.1m | 18.3x | 23.6x | 1.1x |
| Tue, 18 Mar 2025 | €23.0b | €19.6b | €796.0m | 20.7x | 28.8x | 1.2x |
| Thu, 13 Feb 2025 | €26.0b | €20.0b | €828.0m | 23.6x | 31.4x | 1.3x |
| Sat, 11 Jan 2025 | €24.9b | €8.0b | €834.7m | 22.1x | 29.8x | 3.1x |
| Mon, 09 Dec 2024 | €24.6b | €19.0b | €1.4b | 19.2x | 17.2x | 1.3x |
| Wed, 06 Nov 2024 | €24.7b | €18.9b | €1.4b | 16.1x | 18x | 1.3x |
| Fri, 04 Oct 2024 | €24.4b | €18.9b | €1.4b | 17.2x | 17.7x | 1.3x |
| Sun, 01 Sep 2024 | €26.1b | €18.9b | €1.4b | 15.4x | 18.8x | 1.4x |
| Tue, 30 Jul 2024 | €26.0b | €18.8b | €1.4b | 17.1x | 18.8x | 1.4x |
| Thu, 27 Jun 2024 | €25.8b | €18.8b | €1.4b | 16x | 18.6x | 1.4x |
| Sat, 25 May 2024 | €26.0b | €18.8b | €1.4b | 17.2x | 18.8x | 1.4x |
| Mon, 22 Apr 2024 | €25.3b | €18.7b | €1.4b | 19.3x | 18.4x | 1.4x |
| Wed, 20 Mar 2024 | €25.7b | €18.6b | €1.4b | 20.4x | 18.4x | 1.4x |
| Fri, 16 Feb 2024 | €25.0b | €18.6b | €1.4b | 18.7x | 18x | 1.3x |
| Sun, 14 Jan 2024 | €25.3b | €18.6b | €1.4b | 18.1x | 18.2x | 1.4x |
| Tue, 12 Dec 2023 | €23.6b | €18.6b | €1.4b | 18.3x | 16.9x | 1.3x |
| Thu, 09 Nov 2023 | €22.7b | €18.6b | €1.4b | 17x | 16.2x | 1.2x |
| Sat, 07 Oct 2023 | €22.7b | €18.6b | €1.4b | 16.5x | 15.7x | 1.2x |
| Mon, 04 Sep 2023 | €23.8b | €17.3b | €1.1b | 16x | 20.9x | 1.4x |
| Wed, 02 Aug 2023 | €24.0b | €7.8b | €857.4m | 15.3x | 28x | 3.1x |
| Fri, 30 Jun 2023 | €23.9b | €7.7b | €822.5m | 17.5x | 29.1x | 3.1x |
| Sun, 28 May 2023 | €24.2b | €7.7b | €822.5m | 22.6x | 29.4x | 3.1x |
| Tue, 25 Apr 2023 | €24.0b | €7.6b | €826.9m | 21.2x | 29x | 3.2x |
| Thu, 23 Mar 2023 | €22.8b | €7.6b | €868.1m | 19x | 26.3x | 3x |
| Sat, 18 Feb 2023 | €23.9b | €7.4b | €886.1m | 24.7x | 27x | 3.2x |
| Mon, 16 Jan 2023 | €24.0b | €7.4b | €886.1m | 23.9x | 27.1x | 3.2x |
| Wed, 14 Dec 2022 | €25.0b | €7.4b | €886.1m | 22.7x | 28.2x | 3.4x |
Price to Earnings Ratio
28.2x
Current Industry PE
- Investors are relatively neutral on the Italian Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 22.9x.
- The 3-year average PS ratio of 2.0x is lower than the industry's current PS ratio of 2.3x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 5.9% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Italian Healthcare sector?
| IT Market | -0.14% | |
| Healthcare | -1.38% | |
| Healthcare Services | 4.14% | |
| Healthtech | 1.19% | |
| Medical Equipment | 0.57% | |
| Life Sciences | -2.10% | |
| Biotech | -2.77% | |
| Pharma | -4.17% | |
Industry PE
- Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 55.8x.
- Analysts are expecting annual earnings growth of 24.9%, which is lower than the prior year's growth of 116.9% per year.
- Investors are most pessimistic about the Life Sciences industry, which is trading below its 3-year average of 33.7x.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 25% over the next 5 years.
- However this is lower than its past earnings growth rate of 117% per year.
- In contrast, the Biotech industry is expected to see its earnings decline by 77% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AMP Amplifon | €13.89 | 4.9% +€141.9m | -42.9% | PE26.4x | |
| ELN EL.En | €13.05 | 2.8% +€28.0m | 6.4% | PE19.7x | |
| DIA DiaSorin | €62.24 | 0.7% +€24.8m | -39.8% | PE18.2x | |
| GPI GPI | €16.94 | 1.2% +€5.8m | 49.6% | PE30.9x | |
| IMD I.M.D. International Medical Devices | €1.47 | 5.0% +€1.2m | 12.2% | PE19x |
